$0.53
1.54% yesterday
Nasdaq, Nov 25, 09:29 pm CET
ISIN
US7168174081
Symbol
PETV

PetVivo Holdings Inc Stock price

$0.53
+0.03 5.39% 1M
-0.08 13.44% 6M
-7.97 93.79% YTD
-7.97 93.79% 1Y
-7.97 93.79% 3Y
-1.47 73.60% 5Y
-13.52 96.24% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.01 1.54%
ISIN
US7168174081
Symbol
PETV
Sector

Key metrics

Market capitalization $11.01m
Enterprise Value $12.50m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 12.89
P/S ratio (TTM) P/S ratio 11.35
P/B ratio (TTM) P/B ratio 26.09
Revenue growth (TTM) Revenue growth 0.87%
Revenue (TTM) Revenue $970.00k
EBIT (operating result TTM) EBIT $-9.18m
Free Cash Flow (TTM) Free Cash Flow $-6.18m
Cash position $130.00k
EPS (TTM) EPS $-0.50
P/S forward 1.00
EV/Sales forward 1.14
Short interest 1.00%
Show more

Is PetVivo Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

PetVivo Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast PetVivo Holdings Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast PetVivo Holdings Inc:

Buy
100%

Financial data from PetVivo Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.97 0.97
1% 1%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 8.01 8.01
18% 18%
826%
- Research and Development Expense 1.66 1.66
77% 77%
171%
-9.05 -9.05
13% 13%
-933%
- Depreciation and Amortization 0.13 0.13
8% 8%
13%
EBIT (Operating Income) EBIT -9.18 -9.18
12% 12%
-946%
Net Profit -8.62 -8.62
23% 23%
-889%

In millions USD.

Don't miss a Thing! We will send you all news about PetVivo Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PetVivo Holdings Inc Stock News

Neutral
Seeking Alpha
11 days ago
PetVivo Holdings, Inc. (OTCPK:PETV) Q2 2025 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer and General Counsel John Lai - Chief Executive Officer Garry Lowenthal - Chief Financial Officer Conference Call Participants John Dolan Good afternoon, everyone. Thank you for joining us today to discuss PetVivo's Results for its...
Neutral
GlobeNewsWire
12 days ago
MINNEAPOLIS, MN, US, Nov. 14, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal second quarter ended September 30, 2024. All comparisons are to the same year-ago period unless otherwise noted.
Neutral
GlobeNewsWire
15 days ago
MINNEAPOLIS, MN, US, Nov. 11, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Thursday, November 14, 2024 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET...
More PetVivo Holdings Inc News

Company Profile

PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. It is engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The firm's lead product includes Kush, is an intra-articular injection comprised of patented, gel-like biomaterials that is being commercialized for companion animal osteoarthritis. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Minneapolis, MN.

Head office United States
CEO John Lai
Employees 20
Founded 2009
Website www.petvivo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today